Search

Your search keyword '"Leishmania ultrastructure"' showing total 265 results

Search Constraints

Start Over You searched for: Descriptor "Leishmania ultrastructure" Remove constraint Descriptor: "Leishmania ultrastructure"
265 results on '"Leishmania ultrastructure"'

Search Results

51. Modeling and interpretation of extinction spectra of oriented nonspherical composite particles: application to biological cells.

52. Evaluation of antileishmanial activity of eupomatenoid-5, a compound isolated from leaves of Piper regnellii var. pallescens.

53. Furazolidone is a selective in vitro candidate against Leishmania (L.) chagasi: an ultrastructural study.

54. Imaging Leishmania development in their host cells.

55. [Cutaneous leishmaniasis in Damascus].

56. Characterization in vivo and in vitro of a strain of Leishmania (Viannia) shawi from the Amazon Region.

57. Kahalalide F, an antitumor depsipeptide in clinical trials, and its analogues as effective antileishmanial agents.

58. Leishmania amazonensis promastigotes induce and are killed by neutrophil extracellular traps.

59. Electron microscopy and cytochemistry analysis of the endocytic pathway of pathogenic protozoa.

60. Copper (II) complexes of [1,2,4]triazolo [1,5-a]pyrimidine derivatives as potential anti-parasitic agents.

61. The C-terminal extension of Leishmania pifanoi amastigote-specific cysteine proteinase Lpcys2: a putative function in macrophage infection.

62. The putrescine analogue 1,4-diamino-2-butanone affects polyamine synthesis, transport, ultrastructure and intracellular survival in Leishmania amazonensis.

63. The Leishmania tarentolae exosome: purification and structural analysis by electron microscopy.

64. Strategies and results of field emission scanning electron microscopy (FE-SEM) in the study of parasitic protozoa.

65. Unveiling pathways used by Leishmania amazonensis amastigotes to subvert macrophage function.

66. Biological characterization and modes of action of temporins and bombinins H, multiple forms of short and mildly cationic anti-microbial peptides from amphibian skin.

67. Leishmania MAP kinases--familiar proteins in an unusual context.

68. Antileishmanial activity of crude extract and coumarin from Calophyllum brasiliense leaves against Leishmania amazonensis.

69. Alterations on the growth and ultrastructure of Leishmania chagasi induced by squalene synthase inhibitors.

70. Leishmania (Viannia) lainsoni (Silveira et al. 1987): ultrastructural aspects of the parasite and skin lesion in experimentally infected hamster (Mesocricetus auratus).

71. Proteomics and electron microscopic characterization of the unusual mitochondrial ribosome-related 45S complex in Leishmania tarentolae.

72. Leishmania (Viannia) lainsoni: occurrence of intracellular promastigote forms in vivo and in vitro.

73. The role of photosensitizer molecular charge and structure on the efficacy of photodynamic therapy against Leishmania parasites.

74. Activity of and initial mechanistic studies on a novel antileishmanial agent identified through in silico pharmacophore development and database searching.

75. Antileishmanial activity of Eugenol-rich essential oil from Ocimum gratissimum.

76. In vitro responses of human peripheral blood mononuclear cells to whole-cell, particulate and soluble extracts of Leishmania promastigotes.

77. Interleukin-2-activated natural killer cells may have a direct role in the control of Leishmania (Leishmania) amazonensis promastigote and macrophage infection.

78. A novel homologue of coronin colocalizes with actin in filament-like structures in Leishmania.

79. Axenic promastigote forms of Leishmania (Viannia) lainsoni as an alternative source for Leishmania antigen production.

80. Flow cytometric assessment of Leishmania spp metacyclic differentiation: validation by morphological features and specific markers.

81. Synthesis and antileishmanial activities of novel 3-substituted quinolines.

82. Effects of hyperbaric oxygen on Leishmania amazonensis promastigotes and amastigotes.

83. Temporins, small antimicrobial peptides with leishmanicidal activity.

84. Biogenesis of peroxisomes and glycosomes: trypanosomatid glycosome assembly is a promising new drug target.

85. Effect of the lysophospholipid analogues edelfosine, ilmofosine and miltefosine against Leishmania amazonensis.

86. Leishmania in the glomerulus.

87. Cutaneous leishmaniasis in red kangaroos: isolation and characterisation of the causative organisms.

88. A novel form of actin in Leishmania: molecular characterisation, subcellular localisation and association with subpellicular microtubules.

89. Flagellar attachment of Leishmania promastigotes to plastic film in vitro.

90. Mitochondrial localization of the mevalonate pathway enzyme 3-Hydroxy-3-methyl-glutaryl-CoA reductase in the Trypanosomatidae.

91. Ultrastructural and cytochemical identification of megasome in Leishmania (Leishmania) chagasi.

92. Azasterols as inhibitors of sterol 24-methyltransferase in Leishmania species and Trypanosoma cruzi.

93. Ultrastructural and immunological features of experimental cutaneous leishmaniasis after treatment with intralesional hypertonic sodium chloride and CO2 laser rays.

94. A 100-kD complex of two RNA-binding proteins from mitochondria of Leishmania tarentolae catalyzes RNA annealing and interacts with several RNA editing components.

95. Special organelles of some pathogenic protozoa.

96. A simple and reproducible method to obtain large numbers of axenic amastigotes of different Leishmania species.

97. Developmental changes in lysosome morphology and function Leishmania parasites.

98. Cell death in Leishmania induced by stress and differentiation: programmed cell death or necrosis?

99. Inhibition of intracellular proliferation of Leishmania parasites in vitro and suppression of skin lesion development in BALB/c mice by a novel lipid A analog (ONO-4007).

100. Antiproliferative and leishmanicidal effect of ajoene on various Leishmania species: ultrastructural study.

Catalog

Books, media, physical & digital resources